Vaccine Contract Manufacturing Global Market Report 2024 - By Share, Size, Trends, Industry Scope, Forecast To 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Vaccine Contract Manufacturing Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $5.32 billion In 2028 At A CAGR Of 10.1%.
The vaccine contract manufacturing market size has grown strongly in recent years. It will grow from $3.3 billion in 2023 to $3.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to traditional vaccine manufacturing limitations, global disease outbreaks driving vaccine demand, regulatory support for contract manufacturing, increasing complexity of vaccine production, surge in vaccine research and development.

The vaccine contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $5.32 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growing emphasis on pandemic preparedness, increased outsourcing in pharmaceutical manufacturing, expansion of biopharmaceutical companies, accelerated vaccine development timelines, global initiatives for vaccine accessibility. Major trends in the forecast period include integration of single-use technologies in manufacturing, rise in personalized medicine approaches to vaccine development, development of mrna and viral vector vaccines, adoption of continuous manufacturing processes, expansion of fill-finish services.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp

Vaccine Contract Manufacturing Market Major Segments
The vaccine contract manufacturing market covered in this report is segmented -
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary

Key Driver - Rising Vaccination Initiatives Fuel Growth In The Vaccine Contract Manufacturing Market
An increase in initiatives favoring vaccinations is expected to propel the growth of the vaccine contract manufacturing market going forward. Vaccination refers to an easy, safe, and efficient method of defending against contagious diseases before they occur. It boosts the immune system and builds up the body's defenses against infections. Increasing initiatives favoring vaccinations would help advance and develop various vaccine manufacturing processes to support vaccine contract manufacturing. For instance, in November 2022, the U.S. Department of Health and Human Services, a US-based cabinet-level executive branch department of the federal government, announced a new $350 million initiative for HRSA (Health Resources and Services Administration)-supported health facilities to boost the number of COVID-19 vaccines in their communities, with an emphasis on marginalized people. Therefore, the increase in initiatives favoring vaccinations is driving the growth of the vaccine contract manufacturing market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=12216&type=smp

Prominent Trend - Strategic Partnerships Drive Growth In The Vaccine Contract Manufacturing Market
Strategic partnerships are a key trend gaining popularity in the vaccine contract manufacturing market. Significant companies are partnering with the companies operating in the vaccine contract manufacturing market to sustain their position in the market. For instance, in January 2023, Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, partnered with the Coalition for Epidemic Preparedness Innovations, a Norway-based foundation, to finance and coordinate the development of new vaccines and promote the development of Vaxxas' needle-free vaccine patch delivery technology in a project that may eliminate the frozen storage requirement for mRNA vaccines. Furthermore, in January 2021, Novartis AG, a Switzerland-based pharmaceutical company operating in the vaccine contract manufacturing market, partnered with Pfizer Inc., a US-based pharmaceutical company, and BioNTech SE, a Germany-based biotechnology company, to provide manufacturing capacity for the Pfizer-BioNTech COVID-19 vaccine. This partnership helps Novartis take bulk mRNA active ingredients from BioNTech and fill them into vials under aseptic conditions for shipment back to BioNTech for distribution to the healthcare system.

Vaccine Contract Manufacturing Market Players
Major companies operating in the vaccine contract manufacturing market report are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH*, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the vaccine contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Vaccine Contract Manufacturing Market Report Structure
3. Vaccine Contract Manufacturing Market Trends And Strategies
4. Vaccine Contract Manufacturing Market - Macro Economic Scenario
5. Vaccine Contract Manufacturing Market Size And Growth
…..
27. Vaccine Contract Manufacturing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.